“…Furthermore, it has been hypothesized that ZNF594 may influence the usefulness of inhaled 2-adrenergic receptor agonists in the treatment of asthma [ 64 ]. A recent study suggested that the ZNF594 variant may be a new genetic marker for prothrombin time (PT) [ 65 ].…”